PATH vs MBGL
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
PATH · UiPath$10.96 ▼ 2.40%
MBGL · Mobility Global$22.63 ▲ 1.39%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- PATH +4.1%
- MBGL +8.1%
Head to head
| Metric | PATH | MBGL |
|---|---|---|
| Price | $10.96 | $22.63 |
| Change today | ▼ 2.40% | ▲ 1.39% |
| Market cap | $5.71B | $6.67B |
| Return, 3 months | -33.9% | +15.2% |
| Return, year to date | -33.1% | – |
| Return, 1 year | -15.8% | – |
| P/E (TTM) | 16.4 | 70.7 |
| P/B | 2.9 | 0.7 |
| P/E percentile vs own 5y | 81st | 100th |
| Dividend yield | – | 0.27% |
| Revenue growth (YoY, latest qtr) | +13.4% | – |
| Net profit growth (YoY) | +2,178.3% | – |
| Gross margin | 82.6% | – |
| Operating margin | 8.9% | 19.2% |
| Net margin | 21.0% | 8.8% |
| Return on equity | 20.0% | – |
| Analyst target vs. price | +41.9% | +8.3% |
| Analyst buy share | 14% | 13% |
| RSI (14) | 26 | 64 |
| 30-day volatility | 43.7% | 56.1% |
| Max drawdown, 1 year | -51.4% | -25.2% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Hold | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- MBGL is the largest of the group by market value.
- PATH carries the lowest trailing P/E.
- PATH keeps the most profit per dollar of sales.
- PATH has been the calmest stock over the last 30 days.